Boehringer Ingelheim denies rumors on acquisition of Korea’s CJ Healthcare ($896m)

The Korean Herald today has published a release quoting  Boehringer Ingelheim Group’s spokesperson, who denied the rumors – circulating for several days – on Boehringer planning to enter the Korean market through an acquisition. CJ Healthcare has been repeatedly mentioned as the most likely target. The company has an estimated value of at least $986m.

(Source: Korean Herald)